Eli Lilly and Co. announced Wednesday that it will open a new Lilly Gateway Labs site in Philadelphia. The move offers another strong boost to the region’s growing life sciences ecosystem. Lilly will take 44,000 square feet at 2300 Market Street, a Center City life sciences building developed by Breakthrough Properties.

The news follows the Business Journal’s recent report that Lilly planned to expand its footprint in Philadelphia. Now the company has confirmed its commitment, and the project continues to move forward.

Lilly Gateway Labs serve as innovation hubs for early-stage biotech startups. They connect emerging companies with Lilly’s scientific experts, and in doing so, they help accelerate the creation of new medicines. The Philadelphia site will support six to eight startups. It will also include fully equipped wet labs, office space, and shared instrumentation.

Overall, the expansion strengthens Philadelphia’s role as a major life sciences center and gives local biotech founders direct access to global pharmaceutical expertise.

*Article courtesy of Philadelphia Business Journal

For more information about Philadelphia medical space for sale or lease or about any other properties for sale or lease, please contact WCRE at 215-799-6900.

Wolf Commercial Real Estate, a full-service CORFAC International brokerage and advisory firm, is a premier medical commercial real estate broker that provides a full range of commercial real estate listings and services, property management services, and marketing commercial offices, medical, industrial and land, retail buildings and other commercial properties for buyers, tenants, investors, and sellers.

Please visit our website for a full listing of Philadelphia commercial properties for sale or lease, www.wolfcre.com.